Can a common allergy drug plus special sounds restore hearing in noise?
NCT ID NCT07304024
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a one-month treatment combining the allergy drug clemastine fumarate with engineered sound can improve the ability to hear speech in background noise for people aged 45-65 with age-related central auditory processing disorder (CAPD). About 344 participants will be randomly assigned to receive the drug plus sound, drug plus white noise, or placebos. The goal is to see if the treatment helps the brain repair myelin in hearing circuits, making it easier to focus on a conversation in a noisy room.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGE PROBLEM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Colorado Anschutz Medical Center
RECRUITINGAurora, Colorado, 80045, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact Email: •••••@•••••
Contact
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a child's favorite song unlock better hearing tests?
- Chilling the inner ear: a cool new way to shield hearing?
- Chilling the ear canal during cochlear implant surgery may protect residual hearing
- Hearing aid training program may boost benefit for older adults — a trial puts it to the test
- Training parents of disabled children could cut home accidents
- Could a friend help you hear better? new trial tests Peer-Delivered hearing care